280 related articles for article (PubMed ID: 27830515)
21. Preparation & characterization of solid inclusion complex of cefpodoxime proxetil with beta-cyclodextrin.
Bhargava S; Agrawal GP
Curr Drug Deliv; 2008 Jan; 5(1):1-6. PubMed ID: 18220545
[TBL] [Abstract][Full Text] [Related]
22. Nano Spray Drying Technique as a Novel Approach To Formulate Stable Econazole Nitrate Nanosuspension Formulations for Ocular Use.
Maged A; Mahmoud AA; Ghorab MM
Mol Pharm; 2016 Sep; 13(9):2951-65. PubMed ID: 27010795
[TBL] [Abstract][Full Text] [Related]
23. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous delivery of econazole using microemulsion as vehicle: formulation, evaluation and vesicle-skin interaction.
Ge S; Lin Y; Lu H; Li Q; He J; Chen B; Wu C; Xu Y
Int J Pharm; 2014 Apr; 465(1-2):120-31. PubMed ID: 24530389
[TBL] [Abstract][Full Text] [Related]
25. Inclusion complex of 3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) with heptakis(2,6-di-O-methyl)-beta-cyclodextrin: interaction and dissolution properties.
Yamada T; Imai T; Ouchi K; Otagiri M; Hirayama F; Uekama K
Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1264-9. PubMed ID: 10993223
[TBL] [Abstract][Full Text] [Related]
26. Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds.
Fernandes CM; Teresa Vieira M; Veiga FJ
Eur J Pharm Sci; 2002 Feb; 15(1):79-88. PubMed ID: 11803134
[TBL] [Abstract][Full Text] [Related]
27. Preformulation study of the inclusion complex warfarin-beta-cyclodextrin.
Zingone G; Rubessa F
Int J Pharm; 2005 Mar; 291(1-2):3-10. PubMed ID: 15707726
[TBL] [Abstract][Full Text] [Related]
28. Potential Use of Cyclodextrin Complexes for Enhanced Stability, Anti-inflammatory Efficacy, and Ocular Bioavailability of Loteprednol Etabonate.
Soliman OAE; Mohamed EAM; El-Dahan MS; Khatera NAA
AAPS PharmSciTech; 2017 May; 18(4):1228-1241. PubMed ID: 27469220
[TBL] [Abstract][Full Text] [Related]
29. The formation of an inclusion complex between a metabolite of ginsenoside, compound K and γ-cyclodextrin and its dissolution characteristics.
Igami K; Ozawa M; Inoue S; Iohara D; Miyazaki T; Shinoda M; Anraku M; Hirayama F; Uekama K
J Pharm Pharmacol; 2016 May; 68(5):646-54. PubMed ID: 26255976
[TBL] [Abstract][Full Text] [Related]
30. Improvement of solubility and oral bioavailability of 2-(N-cyanoimino)-5-[(E)-4-styrylbenzylidene]-4-oxothiazolidine (FPFS-410) with antidiabetic and lipid-lowering activities in dogs by 2-hydroxypropyl-beta-cyclodextrin.
Hara T; Hirayama F; Arima H; Yamaguchi Y; Uekama K
Chem Pharm Bull (Tokyo); 2006 Mar; 54(3):344-9. PubMed ID: 16508189
[TBL] [Abstract][Full Text] [Related]
31. Solving the Delivery Problems of Triclabendazole Using Cyclodextrins.
Real D; Leonardi D; Williams RO; Repka MA; Salomon CJ
AAPS PharmSciTech; 2018 Jul; 19(5):2311-2321. PubMed ID: 29845501
[TBL] [Abstract][Full Text] [Related]
32. Solid-state characterization and in vitro dissolution behavior of lorazepam: Hydroxypropyl-β-cyclodextrin inclusion complex.
Patel R; Patel M
Drug Discov Ther; 2010 Dec; 4(6):442-52. PubMed ID: 22491310
[TBL] [Abstract][Full Text] [Related]
33. Influence of the preparation method on the physicochemical properties of binary systems of econazole with cyclodextrins.
Mura P; Faucci MT; Manderioli A; Bramanti G
Int J Pharm; 1999 Dec; 193(1):85-95. PubMed ID: 10581425
[TBL] [Abstract][Full Text] [Related]
34. Antifungal activity of econazole nitrate/cyclodextrin complex: Effect of pH and formation of complex aggregates.
Jansook P; Prajapati M; Pruksakorn P; Loftsson T
Int J Pharm; 2020 Jan; 574():118896. PubMed ID: 31765779
[TBL] [Abstract][Full Text] [Related]
35. Development of carvedilol-cyclodextrin inclusion complexes using fluid-bed granulation: a novel solid-state complexation alternative with technological advantages.
Alonso EC; Riccomini K; Silva LA; Galter D; Lima EM; Durig T; Taveira SF; Martins FT; Cunha-Filho MS; Marreto RN
J Pharm Pharmacol; 2016 Oct; 68(10):1299-309. PubMed ID: 27465985
[TBL] [Abstract][Full Text] [Related]
36. Econazole nitrate-loaded MCM-41 for an antifungal topical powder formulation.
Ambrogi V; Perioli L; Pagano C; Marmottini F; Moretti M; Mizzi F; Rossi C
J Pharm Sci; 2010 Nov; 99(11):4738-45. PubMed ID: 20845470
[TBL] [Abstract][Full Text] [Related]
37. Computer-Aided Formulation Design for a Highly Soluble Lutein-Cyclodextrin Multiple-Component Delivery System.
Zhao Q; Miriyala N; Su Y; Chen W; Gao X; Shao L; Yan R; Li H; Yao X; Cao D; Wang Y; Ouyang D
Mol Pharm; 2018 Apr; 15(4):1664-1673. PubMed ID: 29505718
[TBL] [Abstract][Full Text] [Related]
38. Ophthalmic Econazole Hydrogels for the Treatment of Fungal Keratitis.
Díaz-Tomé V; Luaces-Rodríguez A; Silva-Rodríguez J; Blanco-Dorado S; García-Quintanilla L; Llovo-Taboada J; Blanco-Méndez J; García-Otero X; Varela-Fernández R; Herranz M; Gil-Martínez M; Lamas MJ; González-Barcia M; Otero-Espinar FJ; Fernández-Ferreiro A
J Pharm Sci; 2018 May; 107(5):1342-1351. PubMed ID: 29305870
[TBL] [Abstract][Full Text] [Related]
39. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
40. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.
Zhang X; Zhang T; Lan Y; Wu B; Shi Z
AAPS PharmSciTech; 2016 Apr; 17(2):400-8. PubMed ID: 26187778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
